2025 annual financial data
Coherus Oncology 2025 Operating cash flow margin
Direct answer
Operating cash flow margin was -328.45%.
Operating income was -179,534,000 USD and net income was -170,291,000 USD.
Operating cash flow was -138,513,000 USD.
Get free Coherus Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 42,172,000 USD
- Operating income
- -179,534,000 USD
- Net income
- -170,291,000 USD
- Operating cash flow
- -138,513,000 USD